BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Business

  Roche, Forma Cutting Jobs in Massachusetts

  According to WARN notices, the two companies will slash a total of 106 jobs starting in March.

  February 4, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  FDA Rejects Alkermes’ Opioid Modulator Treatment for Depression

  Almost three months to the day after an FDA advisory committee overwhelmingly rejected Alkermes’ major depressive disorder treatment, ALKS-5461, the company received word that the regulatory agency will not approve the medication.

  February 4, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Germany’s Sirion Biotech Launches New U.S. Headquarters in Cambridge

  Sirion Biotech International threw a Bavarian-themed grand opening party at the Forsythe Institute on Feb. 1. The new headquarters are in Cambridge, Mass and currently have five employees.

  February 4, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  You Are Getting Very Sleepy: Eisai and Purdue Pharma Release Phase III Data on Insomnia Drug

  Eisai Co. and Purdue Pharma presented data at the Sleep Research Society’s Conference regarding their lemborexant for the treatment of insomnia. The meeting was held in Clearwater Beach, Florida.

  February 4, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Top 12 Life Sciences Companies Hiring Now in February

  According to a BioSpace Community Survey, almost 70% of life sciences professionals plan to look for a new job in the next 12 months. Don’t delay, accelerate your job search and check out top companies who are looking for quality candidates in 2019!

  February 4, 2019

   · 

  1 min read

   · 

  Editorial Staff
• 

  Business

  BioSpace Hotbed Report: The Surging Tide of Biotech Beach

  The area is home to numerous well-known players in the pharma industry, including Abbott, Iovance, Gossamer Bio, Crown Biosciences, Illumina, Human Longevity and many, many more.

  February 4, 2019

   · 

  3 min read

   · 

  Alex Keown
• Business

  Teijin Board Elects Ichiro Watanabe as New President of Teijin Pharma

  Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, announced that Teijin’s board of directors has elected Ichiro Watanabe, currently corporate officer of the Teijin Group, as its next president.

  February 4, 2019

   · 

  1 min read
• 

  Drug Development

  GenSight’s LHON Gene Therapy Fails to Meet Endpoints at Week 48

  Shares of Paris-based GenSight plunged nearly 19 percent Monday after the company announced that its gene therapy for Leber hereditary optic neuropathy (LHON) failed to show a significant effect in patients at 48 weeks.

  February 4, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  PhRMA and BIO Offer Support of HHS Rebate Proposal, While Insurers Balk at the Plan

  Last week HHS floated a plan that would allow companies to pass rebates of 26 to 30 percent of a drug’s list price directly to patients in order to be reflected in what consumers pay at the pharmacy counter.

  February 4, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Lilly and Incyte’s Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials

  The two Phase III trials are part of a five-trial package the companies are conducting to support potential regulatory approval for this indication.

  February 4, 2019

   · 

  2 min read

   · 

  Alex Keown